| Home : Everads Therapy Enters Into Option Agreement With Global Pharma Company to License Everads' Suprachoroidal Delivery System for Retinal Disease Therapies |
|
Mar 12
2020 |
Everads Therapy Enters Into Option Agreement With Global Pharma Company to License Everads' Suprachoroidal Delivery System for Retinal Disease Therapies |
|
TEL AVIV, Israel, March 12, 2020 /PRNewswire/ -- Everads Therapy, an early-stage life sciences company developing the next generation of retinal treatment delivery technologies, today announced that it has signed an option agreement with a large global pharmaceutical company. This is... |
|
|
|
| Source:https://www.prnewswire.com:443/news-releases/everads-therapy-enters-into-option-agreement-with-global-pharma-company-to-license-everads-suprachoroidal-delivery-system-for-retinal-disease-therapies-301021829.html |
| |
|
Related News
|
» Suning International Donates Medical Masks to Italy to Support the Fight Against the Coronavirus
» Uber treibt mit Mixpanel die kundenorientierte Innovation voran
|
